Webinars, Pharmaceutical

Aptar Pharma Hosts Webinar on Optimizing Preclinical Programs for Intranasal and Pulmonary Programs

Aptar Pharma is set to host an engaging and informative live webinar titled “Optimizing Preclinical Programs for Intranasal and Pulmonary Programs”

Join this webinar on:

March 26, 2024
9:00 AM London / 4:00 PM Beijing


March 26, 2024 3:30 PM London / 11:30 AM New York
Register for 9am London Session Register for 3:30pm London Session
Presented by Julie D. Suman, Aptar Pharma Conor A. Ruzycki, Lovelace Biomedical
22 Jan 2024

Aptar Pharma is proud to sponsor an upcoming webinar titled “Optimizing Preclinical Programs for Intranasal and Pulmonary Programs,” for the review of drug development and preclinical studies. This webinar will shed light on the critical role of drug delivery systems in the design of preclinical studies for pulmonary and nasal drug therapies.

Preclinical studies serve as a cornerstone in assessing the feasibility and safety of new drugs. While scientific guidelines exist from entities like the FDA and European Medicines Agency for non-clinical testing, the selection of drug delivery systems within preclinical studies remains an area less standardized.

This webinar aims to fill this knowledge gap by discussing the significance of drug delivery systems in the design of preclinical pulmonary and nasal drug studies. Experts will explore existing delivery strategies across various animal species, with a focus on the pros and cons of administration in small animals such as mice and rats.

The session will also delve into several case studies showcasing intranasal drug delivery using novel insufflators and micro-sprayers. The benefits and strategies for designing effective preclinical programs utilizing these innovative platforms will be thoroughly examined.

This webinar will be led by two experts in the field; Dr Julie Suman, Vice President Scientific Affairs, Aptar Pharma and Dr. Conor Ruzycki, Associate Research Specialist at Lovelace Biomedical, both of whom bring extensive experience and knowledge in preclinical drug development and delivery systems.

By attending this webinar, attendees will gain insights into navigating the complexities inherent in preclinical research and discover the methodologies involved in preclinical studies, particularly in small animal models. The expert speakers will also provide guidance on strategizing and planning effective preclinical programs in line with current scientific and regulatory frameworks.

The webinar is expected to be of interest to Heads of Research and Development, University Research Departments, Veterinary Researchers, New Product Development Teams, Hospital Clinical Researchers, Scientific Collaborators, Scientists, and Senior Scientists.

For more information and to register for this enlightening webinar, please click on the links below.
Don’t miss this opportunity to gain invaluable insights and knowledge from leading experts in the field.

Register for 9am London Session

Register for 3:30pm London Session


About Aptar Pharma

Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 countries.
For more information, visit www.aptar.com/pharmaceutical

Back To Top